Key Market Indicators
By 2026, Canada is projected to reach 1,690 influenza-related deaths. This is a 2.8% average annual growth rate since 1965, when the death rate was 16.2%. Canada was the fourth-highest in the world for influenza-related deaths in 2021, with 1,420 fatalities. Japan, Germany and Canada respectively came in second, third, and fourth place in the rankings.
Canada Infectious Disease Market Data and Forecasts
How much will Canada Infectious Disease Market grow to 2026?
More in Infectious Disease Industry for 2028Improve your Knowledge with the latest Indicators and Trends
-
Viral Infections: Unmasking the Developing Trends and Opportunities in HHV-4 and HHV-5 Pipelines
The landscape of Herpesviruses (HHV) 4 and 5 infections, widely known as Epstein-Barr Virus (EBV) and Cytomegalovirus (CMV) respectively, has experienced significant changes in the recent past. Challenges in developing effective treatments have led to a heightened focus on research, with several new drugs in the pipeline. Current attention has...
Discover more insights -
Pharmaceutics Impact: Delving Into the Global Tuberculosis Treatment Drugs Market Landscape
Growing demands for more effective treatments in response to the expanding global tuberculosis (TB) burden have marked the present landscape of the TB drugs market. Constant advancements in research and development have led to the introduction of novel products, while the presence of robust distribution networks facilitates reach to global...
Discover more insights -
Influenza A Virus: Unpacking Subtype Trends in Pipeline Reviews
The Influenza A virus market segment remains essential, due to the recurrent need for effective vaccines and treatments. The industry is marked by iterative advancements, where prevailing therapeutic strategies are often displaced by newer ones. This is necessitated by the virus's propensity for mutation, a factor that underlines the importance...
Discover more insights -
Infectious Disease Market: Analysis, Emerging Technologies, and Opportunities for Suppliers
In terms of diagnostic technologies for infectious diseases, the landscape presents as ever-evolving. Suppliers are constantly engaged in the development and refinement of detection techniques, targeting early identification of a broad spectrum of infections. These innovations play a vital role in patient treatment and long-term disease management within all healthcare...
Discover more insights -
Infectious Disease Market: Analyzing Opportunities and Competitive Landscape in Technology Trends
The infectious disease market is evolving in response to ongoing public health challenges, such as the COVID-19 pandemic. This market features various sectors focusing on the development and distribution of vaccines, antivirals, antibiotics, and diagnostic tests. Market growth is primarily driven by factors such as increased incidences of infectious diseases,...
Discover more insights